CareLit · DOI-Nachweis · Aktuelle Neurologie
Levetiracetam in central post-stroke pain: a randomized, double-blind, placebo-controlled trial
DOI 10.1055/s-0028-1086618
Bibliografische Angaben
Nachweis in CareLit
Autor:innenG.J Jungehülsing, H Israel, N Safar, B Taskin, C.H Nolte, K.D Wernecke, A Villringer
ZeitschriftAktuelle Neurologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Central post-stroke pain (CPSP) is a severe and distressing pain condition. Treatment of CPSP is based on amitriptyline and anti-epileptic drugs (AED) but limited by side effects and unsatisfying efficacy. Levetiracetam (LEV) is a novel AED with a favourable adverse event and safety profile. Experimental neuropathic animal and human pain models show an analgesic effect of LEV. Objective: To examine effic…
Zitieren
Zitierempfehlung
G.J Jungehülsing, H Israel, N Safar, B Taskin, C.H Nolte, K.D Wernecke, A Villringer (2008) Levetiracetam in central post-stroke pain: a randomized, double-blind, placebo-controlled trial. Aktuelle Neurologie (09). https://doi.org/10.1055/s-0028-1086618
Mit CareLit weiterarbeiten